TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15067 · Aug 16

#php#agent#agi#ai#gpt#llm#low_code#mcp#no_code#sandbox#workflow Magic is an open-source AI platform that helps businesses quickly build and use AI tools to boost productivity by up to 100 times. It offers a complete set of AI products, including a smart AI agent for complex tasks, an AI-powered chat system for team communication, and a visual tool to create AI workflows without coding. These tools work together to improve decision-making, automate tasks, and enhance collaboration securely within organizations. You can try Magic via cloud services or self-host it, making it flexible and powerful for different business needs. This platform saves time, improves efficiency, and supports smarter teamwork. https://github.com/dtyq/magic

Results

3 similar posts found

Search: #genetherapy

当前筛选 #genetherapy清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3846 · 01/11/2025, 10:00 AM

Funding Rounds Boost Healthcare & Energy Sectors Several companies have recently secured significant funding: - Arizona Public Service: $1.81B, Jan 8, 2025. - Nephron Pharmaceuticals: $350M, Jan 10, 2025. - Windward Bio: $200M, Jan 10, 2025. - Timberlyne Therapeutics: $180M, Jan 10, 2025. - Hippocratic AI: $141M, Jan 9, 2025. - Ouro Medicines: $120M, Jan 10, 2025. - Movement Labs: $100M, Jan 8, 2025. - Rhygaze: $86M, Jan 10, 2025. - Light Horse Therapeutics: $62M, Jan 9, 2025. - Overhaul: $55M, Jan 10, 2025. - Numab: $54.94M, Jan 9, 2025. - Harsoria Healthcare: $20M, Jan 9, 2025. - Huazhi Energy: $13.64M, Jan 8, 2025. - Lava Network: $12M, Jan 9, 2025. - Pakistan Refinery Ltd: $11.24M, Jan 8, 2025. Find detailed updates on respective company websites for more insights. #Funding#Healthcare#Biotech#Energy#Pharmaceuticals#AI#Tech#GeneTherapy#Blockchain#VentureCapital#Investment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 12/18/2024, 12:11 PM

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform